share_log
Benzinga ·  Feb 18 20:29
Ascendis Pharma Shares Are Trading Higher After Evercore ISI Raised Its Price Target on the Stock From $220 to $260
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 323

Recommended

Write a comment